Literature DB >> 8803677

Beta 1-adrenoceptor autoimmunity in cardiomyopathy.

Y Magnusson1, A Hjalmarson, J Hoebeke.   

Abstract

A growing body of studies have confirmed that autoantibodies against beta 1-adrenoceptors are present in different types of cardiomyopathy. This suggests that they play a role in the pathophysiology of the disease. This article will review the data indicating the presence of anti-beta 1-adrenoceptor autoantibodies in cardiomyopathy. It will focus upon their structural and functional properties which could explain their possible role in the induction and development of cardiomyopathic diseases.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8803677     DOI： 10.1016/0167-5273(96)02590-9

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  8 in total

1.  Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents.

Authors:  Kun Liu; Yu-Hua Liao; Zhao-Hui Wang; Shu-Li Li; Ming Wang; Ling-Lan Zeng; Ming Tang
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

Review 2.  Autoantibodies and cardiovascular dysfunction: cause or consequence?

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 3.  Receptor-activating autoantibodies and disease: preeclampsia and beyond.

Authors:  Yang Xia; Rodney E Kellems
Journal:  Expert Rev Clin Immunol       Date:  2011-09       Impact factor: 4.473

4.  Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.

Authors:  Yuji Nagatomo; Daniel Li; Jennifer Kirsop; Alan Borowski; Akanksha Thakur; W H Wilson Tang
Journal:  J Card Fail       Date:  2016-03-17       Impact factor: 5.712

5.  Antibodies to cardiac receptors.

Authors:  V Boivin-Jahns; A Schlipp; S Hartmann; P Panjwani; K Klingel; M J Lohse; G Ertl; R Jahns
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

Review 6.  Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function.

Authors:  L R Herda; S B Felix; F Boege
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

7.  Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.

Authors:  Beatrice Bornholz; Stefanie Weidtkamp-Peters; Stephanie Schmitmeier; Claus A M Seidel; Lars R Herda; Stephan B Felix; Horst Lemoine; Jürgen Hescheler; Filomain Nguemo; Christoph Schäfer; Morten O Christensen; Christian Mielke; Fritz Boege
Journal:  Cardiovasc Res       Date:  2012-12-03       Impact factor: 10.787

8.  β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.

Authors:  Yunhui Du; Li Yan; Jin Wang; Wenzhang Zhan; Kai Song; Xue Han; Xiao Li; Jimin Cao; Huirong Liu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.